On the new Ask Us Anything podcast, editor in chief Kaitlin Petersen taps former Trade Tales guests to answer real, ...

The first clinical data in non-small cell lung cancer from the Phase 1 study of zoldonrasib, a RAS(ON) G12D-selective inhibitor, will be featured in a late breaking oral presentation.

With time running out and the stakes high, the task of designing slides that do justice to your thinking feels overwhelming. A generative AI tool like Gamma.app eases that burden by converting ...

Most recently, Ashwin criticised the IPL for prioritising batting during its post-game presentation shows, to the detriment of bowlers. Ravichandran Ashwin celebrates a wicket with MS Dhoni in the ...

Tonix Pharmaceuticals Holding Corp. CHATHAM, N.J., March 27, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with ...

today announced that the Company will have three presentations at the American Association for Cancer Research (AACR) Annual Meeting from April 25-30, 2025 in Chicago, IL.

During a Tuesday city council meeting it approved the termination, citing outdated terms in the MOU and a determination that it was not necessary to formally define co-presentations. Wheeler ...

CD3 T-cell engagers have the potential to be a cornerstone of cancer treatment. They guide the immune system to find and eliminate cancer cells by binding tumor targets and the CD3 protein on ...